Locus 131: LIPG (18q21.1)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs2187375 |
X-03094 |
A/G |
7356 |
0.17 |
-0.022 (0.003) |
2.65·10-17 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs2187375 |
| Chromosomal location | Chr18: 45,426,281 (18q21.1) |
| Gene (distance) | LIPG (53,006) |
| Predicted causal gene | LIPG |
| Gene/protein classification | - |
| Metabolite (Pathway) | X-03094 (Unknown) |
| Biochemical locus-metabolite relationship | LIPG, the endothelial lipase, has been associated with HDL cholesterol in many studies [22607825]. X-03094 is a GGM neighbor of cholesterol [23093944]. |
| eQTL associations | LIPG (L) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Pharmacological information |
| ChEMBL ID | CHEMBL5080 |
| Drug information |
Compounds with activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

